| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |